BASE GENE THERAPEUTICS LIMITED
BENNETT BROOKS & CO. LIMITED 14 GROSVENOR COURT, FOREGATE STREET, CHESTER CH1 1HG- Active
- Private Limited Company
- Company No. 14202879
- Last Updated: 01 Mar 2024
Company Profile
BASE GENE THERAPEUTICS LIMITED was incorporated on Wednesday, June 29, 2022 as a Private Limited Company with registered address in CHESTER. BASE GENE THERAPEUTICS LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 2 years 4 months and 11 days.
| Name | BASE GENE THERAPEUTICS LIMITED |
|---|---|
| Company number | 14202879 |
| Company type | Private Limited Company |
| Incorporation date | 29 Jun 2022 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
BENNETT BROOKS & CO. LIMITED 14 GROSVENOR COURT FOREGATE STREET CHESTER CH1 1HG |
|---|---|
| Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Mr Michael Patrick Cunniffe Nationality: English |
Dates: Wednesday, June 29, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
| Mr Philip Leslie Beales Nationality: British |
Dates: Wednesday, June 29, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
| Type of accounts | NO ACCOUNTS FILED |
|---|---|
| End of financial Year | 30 June |
| Next annual accounts due | 29 March 2024, (-226 days left) |
| Latest accounts | Not available |
| Next confirmation statement due | 27 July 2023 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against BASE GENE THERAPEUTICS LIMITED.
Previous Names
| Name | Change Date |
|---|---|
| BASE GENE THERAPEUTICS LIMITED | 29 Jun 2022 |